GSK offers $1 billion to raise stake in Indian unit

The UK-listed group offers to raise its stake in GlaxoSmithKline Pharmaceuticals, its Indian drug unit, boosting its investment in the country.

To continue reading, please login or register for free

Print Edition

FinanceAsia Print Edition

CONFERENCES